CulturPlate-384, White Opaque 384-well Microplate, Sterile and Tissue Culture Treated, Case of 50 | PerkinElmer

幸运8平台彩票

PerkinElmer
check quantity

CulturPlate-384, White Opaque 384-well Microplate, Sterile and Tissue Culture Treated, Case of 50

幸运8平台彩票 384-well white tissue culture-treated (TC-treated) sterile microplate for cell-based assays

项目已成功添加到购物车

部件号
产品尺寸
6007680
Case of 50
更多
6007688
Case of 160
更多
6007689
Case of 200
更多
立即购买

请输入有效的数量

请登录后再添加至收藏夹

幸运8平台彩票 购物车为空

详情 信息

幸运8平台彩票The CulturPlate is PerkinElmer's microplate designed for cellular assays, tissue-culture treated and sterilized by gamma-irradiation to facilitate adherent cell growth. The optimized well design and high quality plastics provides low background and crosstalk.

幸运8平台彩票CulturPlates are uniquely engineered to be the same height for 96-, 384-, and 1536-well plates, and with extraordinary well flatness for ease in automation.

Leveraging years of assay and instrument experience in plate detection, PerkinElmer designs better Microplates for better performance that guarantees better results for all PerkinElmer applications.

规格

自动化兼容 Yes
涂层处理 TC-treated, Sterile
颜色 White
检测方法 Time-Resolved Fluorescence (TRF), Luminescence, Alpha, Radiometric
Material Polystyrene
产品品牌名称 CulturPlate
运输条件 环境
Sterile Yes
产品尺寸 Case of 50
阱数量 384 well plate
资源,活动及更多信息
  • 所有

应用文献

Measuring PD-L1 and PD-1 Expression in Human Cells with LANCE Ultra TR-FRET

幸运8平台彩票Immuno-oncology is an exciting area within cancer research and among the most promising approaches to activating therapeutic antitumor immunity is through the blockade of immune checkpoints. The programmed cell death-1 (PD-1) immune checkpoint pathway is a negative regulator of T cell immune function. When PD-1 is bound to programmed cell death-ligand 1 (PD-L1), T cell response is suppressed. Many tumor cells escape anti-tumor immunity through their expression of Programmed Death Ligand 1 (PD-L1 or B7-H1), which interacts with T cell-expressed PD-1 and results in T cell apoptosis. PD-L1 expression has been studied in multiple different cancers. While several anti-PD-1 or PD-L1 monoclonal antibodies that block the PD-1/ PD-L1 complex formation have been developed to date, there remains a need for more robust, rapid, high-throughput assays to identify and qualify novel inhibitors of PD-1/PD-L1 binding and assays to detect expression levels of both binding partners. Find out how LANCE® Ultra Technology provides a fast, powerful, homogeneous platform for identifying and characterizing endogenous PD-L1 and PD-1 expression in human cells.

PDF 4 MB

海报

High Sensitivity cAMP Assays in Primary Cells and Mesenchymal Stem Cells with the LANCE® Ultra cAMP kit

Poster on High Sensitivity cAMP Assays in Primary Cells and Mesenchymal Stem Cells with the LANCE® Ultra cAMP kit

PDF 114 KB